Haemonetics Appoints Frank Chan As Executive Vice President, Chief Operating Officer; Roy Galvin As Executive Vice President, Chief Commercial Officer
Haemonetics Appoints Frank Chan As Executive Vice President, Chief Operating Officer; Roy Galvin As Executive Vice President, Chief Commercial Officer
03/03/25, 9:18 PM
Location
bostonIndustry
medical
biotechnology
Position
chief operating officer
vice president
vice president
chief commercial officer
Haemonetics Corporation announced the appointment of Frank Chan, Ph.D. as Executive Vice President, Chief Operating Officer effective April 7, 2025, and the appointment of Roy Galvin as the company's Executive Vice President, Chief Commercial Officer, effective immediately.
Company Info
Location
boston, massachusetts, united states
Additional Info
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.